Acadia Pharmaceuticals
ACAD
ACAD
168 hedge funds and large institutions have $2.21B invested in Acadia Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 63 increasing their positions, 53 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6% more capital invested
Capital invested by funds: $2.08B → $2.21B (+$132M)
45% less funds holding in top 10
Funds holding in top 10: 11 → 6 (-5)
Holders
168
Holding in Top 10
6
Calls
$335M
Puts
$23M
Top Buyers
| 1 | +$38M | |
| 2 | +$36.2M | |
| 3 | +$24.2M | |
| 4 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$23.9M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$23.5M |
Top Sellers
| 1 | -$22.4M | |
| 2 | -$21.4M | |
| 3 | -$15.2M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$12.2M |
| 5 |
CCI
Columbus Circle Investors
|
-$10.8M |